Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study
Research output: Contribution to journal › Journal article › Research › peer-review
Liver diseases are the leading causes of death in human immunodeficiency virus (HIV)-positive persons since the widespread use of combination antiretroviral treatment (cART). Most of these deaths are due to hepatitis C (HCV) or B (HBV) virus coinfections. Little is known about other causes. Prolonged exposure to some antiretroviral drugs might increase hepatic mortality.
| Original language | English |
|---|---|
| Journal | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
| Volume | 56 |
| Issue number | 6 |
| Pages (from-to) | 870-9 |
| Number of pages | 10 |
| DOIs | |
| Publication status | Published - Mar 2013 |
- Adult, Anti-Retroviral Agents, Antiretroviral Therapy, Highly Active, Data Collection, Drug-Related Side Effects and Adverse Reactions, Female, Follow-Up Studies, HIV Infections, Humans, Incidence, Liver Failure, Male, Middle Aged, Prospective Studies, Survival Analysis
Research areas
ID: 105603520